Research Ireland’s Rinn Pharma & Biopharma, Ireland’s national centre for research and innovation in the manufacturing of medicines, has today (7 August) announced its inclusion in the NordicPharmaTrain (NPT) network. NPT is a European research and training network that connects academic and industry partners with the aim of advancing pharmaceutical innovation. Rinn Pharma & Biopharma’s inclusion aims to enhance NPT’s network of research institutions and industry collaborators, strengthening cross-border collaboration and accelerating scientific progress within the larger pharmaceutical sector. Commenting on the announcement, Prof Damien Thompson, the director of Rinn Pharma & Biopharma, said, “By joining NordicPharmaTrain, we are accelerating Ireland’s role in delivering innovative pharmaceutical solutions. In late July, it was announced that Rinn Pharma & Biopharma and Cork-based biotech spin-out ArrayPatch would collaborate on developing a novel skin cancer treatment using a patented dissolvable microneedle platform.